These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 31235585)

  • 41. Structural analysis and evolution of specificity of the SUMO UFD E1-E2 interactions.
    Liu B; Lois LM; Reverter D
    Sci Rep; 2017 Feb; 7():41998. PubMed ID: 28165030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noncanonical E2 recruitment by the autophagy E1 revealed by Atg7-Atg3 and Atg7-Atg10 structures.
    Kaiser SE; Mao K; Taherbhoy AM; Yu S; Olszewski JL; Duda DM; Kurinov I; Deng A; Fenn TD; Klionsky DJ; Schulman BA
    Nat Struct Mol Biol; 2012 Dec; 19(12):1242-9. PubMed ID: 23142976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. E1-L2 activates both ubiquitin and FAT10.
    Chiu YH; Sun Q; Chen ZJ
    Mol Cell; 2007 Sep; 27(6):1014-23. PubMed ID: 17889673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structure of a fragment of mouse ubiquitin-activating enzyme.
    Szczepanowski RH; Filipek R; Bochtler M
    J Biol Chem; 2005 Jun; 280(23):22006-11. PubMed ID: 15774460
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Largazole and its derivatives selectively inhibit ubiquitin activating enzyme (e1).
    Ungermannova D; Parker SJ; Nasveschuk CG; Wang W; Quade B; Zhang G; Kuchta RD; Phillips AJ; Liu X
    PLoS One; 2012; 7(1):e29208. PubMed ID: 22279528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Substrate properties of site-specific mutant ubiquitin protein (G76A) reveal unexpected mechanistic features of ubiquitin-activating enzyme (E1).
    Pickart CM; Kasperek EM; Beal R; Kim A
    J Biol Chem; 1994 Mar; 269(10):7115-23. PubMed ID: 8125920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of conjugation specificity determinants unmasks vestigial preference for ubiquitin within the NEDD8 E2.
    Huang DT; Zhuang M; Ayrault O; Schulman BA
    Nat Struct Mol Biol; 2008 Mar; 15(3):280-7. PubMed ID: 18264111
    [TBL] [Abstract][Full Text] [Related]  

  • 48. β-Sheet Augmentation Is a Conserved Mechanism of Priming HECT E3 Ligases for Ubiquitin Ligation.
    Jäckl M; Stollmaier C; Strohäker T; Hyz K; Maspero E; Polo S; Wiesner S
    J Mol Biol; 2018 Sep; 430(18 Pt B):3218-3233. PubMed ID: 29964046
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structure of the Schizosaccharomyces pombe U7BR E2-binding region in complex with Ubc7.
    Hann ZS; Metzger MB; Weissman AM; Lima CD
    Acta Crystallogr F Struct Biol Commun; 2019 Aug; 75(Pt 8):552-560. PubMed ID: 31397327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The family of ubiquitin-conjugating enzymes (E2s): deciding between life and death of proteins.
    van Wijk SJ; Timmers HT
    FASEB J; 2010 Apr; 24(4):981-93. PubMed ID: 19940261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Site-Specific Protein Ubiquitylation Using an Engineered, Chimeric E1 Activating Enzyme and E2 SUMO Conjugating Enzyme Ubc9.
    Akimoto G; Fernandes AP; Bode JW
    ACS Cent Sci; 2022 Feb; 8(2):275-281. PubMed ID: 35237717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissecting the Specificity of Adenosyl Sulfamate Inhibitors Targeting the Ubiquitin-Activating Enzyme.
    Misra M; Kuhn M; Löbel M; An H; Statsyuk AV; Sotriffer C; Schindelin H
    Structure; 2017 Jul; 25(7):1120-1129.e3. PubMed ID: 28578874
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The intrinsic affinity between E2 and the Cys domain of E1 in ubiquitin-like modifications.
    Wang J; Hu W; Cai S; Lee B; Song J; Chen Y
    Mol Cell; 2007 Jul; 27(2):228-237. PubMed ID: 17643372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression, purification, and crystal structure of N-terminal domains of human ubiquitin-activating enzyme (E1).
    Xie ST
    Biosci Biotechnol Biochem; 2014; 78(9):1542-9. PubMed ID: 25209502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. UbFluor: A Fluorescent Thioester to Monitor HECT E3 Ligase Catalysis.
    Krist DT; Foote PK; Statsyuk AV
    Curr Protoc Chem Biol; 2017 Mar; 9(1):11-37. PubMed ID: 28253433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. E1-catalyzed ubiquitin C-terminal amidation for the facile synthesis of deubiquitinase substrates.
    Wang XA; Kurra Y; Huang Y; Lee YJ; Liu WR
    Chembiochem; 2014 Jan; 15(1):37-41. PubMed ID: 24357003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanistic studies of substrate-assisted inhibition of ubiquitin-activating enzyme by adenosine sulfamate analogues.
    Chen JJ; Tsu CA; Gavin JM; Milhollen MA; Bruzzese FJ; Mallender WD; Sintchak MD; Bump NJ; Yang X; Ma J; Loke HK; Xu Q; Li P; Bence NF; Brownell JE; Dick LR
    J Biol Chem; 2011 Nov; 286(47):40867-77. PubMed ID: 21969368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systematic determinations of SUMOylation activation intermediates and dynamics by a sensitive and quantitative FRET assay.
    Song Y; Liao J
    Mol Biosyst; 2012 Jun; 8(6):1723-9. PubMed ID: 22466055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structural insights into the conformation and oligomerization of E2~ubiquitin conjugates.
    Page RC; Pruneda JN; Amick J; Klevit RE; Misra S
    Biochemistry; 2012 May; 51(20):4175-87. PubMed ID: 22551455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Structural and biochemical studies of the open state of Lys48-linked diubiquitin.
    Lai MY; Zhang D; Laronde-Leblanc N; Fushman D
    Biochim Biophys Acta; 2012 Nov; 1823(11):2046-56. PubMed ID: 22542781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.